Arwa F. Flemban

Machine learning-based identification of targeted metabolomic biomarkers for early diagnosis and fibrosis-stage discrimination in metabolic dysfunction-associated steatotic liver disease

Machine learning applied to targeted blood and urinary metabolomics identified candidate metabolite signatures associated with early-stage MASLD and fibrosis stage and developed machine learning models for case discrimination and fibrosis-stage stratification.